Transition Physiology · Symptom Patterns
Migraine across the menopausal transition and beyond: A narrative review
Korn TF et al., 2026
118 works
Perimenopause and Menopause
The hormonal transition, its symptoms, and restorative and hormonal options for the years around it.
In Perimenopause and Menopause
118 works
Hormone Therapy · Benefits and Risks
Don't ignore perimenopause
Prior JC et al., 2023
Hormone Therapy · Benefits and Risks
Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial
Prior JC et al., 2023
Hormone Therapy · Benefits and Risks
Impact of progesterone on the gastrointestinal tract: a comprehensive literature review
Coquoz A et al., 2022
Transition Physiology · Symptom Patterns
Resilience and psychosocial factors linked to symptom experience during the menopause transition for women living with HIV
King EM et al., 2022
Hormone Therapy · Benefits and Risks
Progesterone for treatment of symptomatic menopausal women
Prior JC, 2018
Long Term Health · Cognitive Health
Ginseng for managing menopausal woman's health: A systematic review of double-blind, randomized, placebo-controlled trials
Lee HW et al., 2016
Hormone Therapy · Benefits and Risks
Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound
Prior JC et al., 2012
Long Term Health · Cardiovascular Health
Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women
Hitchcock CL et al., 2012
Hormone Therapy · Bioidentical Hormones
Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women
Hitchcock CL et al., 2012
Hormone Therapy · Bioidentical Hormones
Progesterone for Symptomatic Perimenopause Treatment - Progesterone politics, physiology and potential for perimenopause
Prior JC, 2011
Transition Physiology · Cycle Changes
The endocrinology of perimenopause: need for a paradigm shift
Prior JC et al., 2011
Hormone Therapy · Benefits and Risks
Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy
Prior JC et al., 2007
Hormone Therapy · Benefits and Risks
Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance
Prior JC et al., 2007
Hormone Therapy · Benefits and Risks
Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study
Rotem C et al., 2007
Transition Physiology · Symptom Patterns
Perimenopause lost—reframing the end of menstruation
Prior et al., 2006
Hormone Therapy · Benefits and Risks
[The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women]
Rozmus-Warcholińska W et al., 2004
Transition Physiology · Symptom Patterns
Cyclicity of breast tenderness and night-time vasomotor symptoms in mid-life women: information collected using the Daily Perimenopause Diary
Hale GE et al., 2003
Transition Physiology · Symptom Patterns
The impact of testosterone imbalance on depression and women's health
Rohr UD, 2002
Hormone Therapy · Benefits and Risks
Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review
MacLennan A et al., 2001
Hormone Therapy · Benefits and Risks
Preserved forearm endothelial responses with acute exposure to progesterone: A randomized cross-over trial of 17-beta estradiol, progesterone, and 17-beta estradiol with progesterone in healthy menopausal women
Mather KJ et al., 2001
Hormone Therapy · Bioidentical Hormones
Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey
Fitzpatrick LA et al., 2000
Hormone Therapy · Benefits and Risks
Efficacy and safety of oral estriol for managing postmenopausal symptoms
Takahashi K et al., 2000
Hormone Therapy · Benefits and Risks
Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss
Leonetti HB et al., 1999
Transition Physiology · Cycle Changes
Perimenopause: the complex endocrinology of the menopausal transition
Prior JC, 1998
Hormone Therapy · Benefits and Risks
Vascular responses to 17 beta-oestradiol in postmenopausal women
Riedel M et al., 1995
Also filed here
Reproductive Aging · Ovarian Aging
Estropausal gut microbiota transplant improves measures of ovarian function in adult mice
Kim M et al., 2026
Reproductive Aging · Ovarian Aging
Impacts of fetal/infant and adolescent exposure to famine on age at menopause in Chinese women
Wang H et al., 2025
Associated Conditions · Comorbid Conditions
Association between endometriosis and type and age of menopause: a pooled analysis of 279 948 women from five cohort studies
Chung HF et al., 2025
Hormonal Agents · Estrogen Preparations
Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses
Baik SH et al., 2024
Hormonal Agents · Estrogen Preparations
Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women
Tan-Kim J et al., 2023
Hormonal Agents · Androgens and DHEA
Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery
Nowakowski Ł et al., 2023
Cycle Across the Lifespan · Cycle and General Health
Menstrual cycle length variation by demographic characteristics from the Apple Women's Health Study
Li H et al., 2023
Reproductive Aging · Ovarian Aging
Age at Natural Menopause in Women Living with HIV: A Cross-Sectional Study Comparing Self-Reported and Biochemical Data
Swann SA et al., 2023
Hormonal Agents · Estrogen Preparations
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Cho L et al., 2023
Hormones and Aging Tissues · Cardiometabolic Aging
Metabolic Disorders in Menopause
Jeong HG et al., 2022
Ovarian Hormones · Estrogen
Spotlight on the Gut Microbiome in Menopause: Current Insights
Peters BA et al., 2022
Reproductive Aging · Cycle Changes With Age
Menstruation and menopause in autistic adults: Periods of importance?
Groenman AP et al., 2022
Guidelines by Clinical Area · Bone and Endocrine Guidelines
The 2022 hormone therapy position statement of The North American Menopause Society
“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel, 2022
Ovarian Hormones · Estrogen
The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response and meta-analysis of randomized clinical trials
Zhu Y et al., 2021
Hormonal Agents · Estrogen Preparations
Menopausal hormone therapy for women living with HIV
King EM et al., 2021
Bone Mineral Density · Measurement
Faster Lumbar Spine Bone Loss in Midlife Predicts Subsequent Fracture Independent of Starting Bone Mineral Density
Shieh A et al., 2021
Environmental Exposures · Endocrine Disrupting Chemicals
Urinary phthalate metabolite concentrations and hot flashes in women from an urban convenience sample of midlife women
Warner GR et al., 2021
Add-Ons and Adjuncts · Adjunct Evidence Base
Resumed ovarian function and pregnancy in early menopausal women by whole dimension subcortical ovarian administration of platelet-rich plasma and gonadotropins
Hsu CC et al., 2021
Cycle Across the Lifespan · Cycle and General Health
Prevalence of hormone-related mood disorder symptoms in women with ADHD
Dorani F et al., 2021
Sexual Function · Arousal and Orgasm
Sexual behaviors and function during menopausal transition-does menopausal hormonal therapy play a role?
Nowosielski K et al., 2020
Guidelines by Issuing Body · Specialty and Consensus Panels
Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society
Rabijewski M et al., 2020
Hormonal Agents · Estrogen Preparations
The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
González-Rodríguez A et al., 2019
Reproductive Aging · Ovarian Aging
Can Menopause Prediction Be Improved With Multiple AMH Measurements? Results From the Prospective Doetinchem Cohort Study
de Kat AC et al., 2019
Neuroendocrinology · Hypothalamic Pituitary Axis
Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance
Del Río JP et al., 2018
Bone Mineral Density · Measurement
Women's Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
Wong EMM et al., 2018
Hormones and Bone · Estrogen and Bone
Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization
Prior JC et al., 2017
Environmental Exposures · Endocrine Disrupting Chemicals
Phthalate metabolite levels and menopausal hot flashes in midlife women
Ziv-Gal A et al., 2016
Stress and Allostatic Load · Stress and Ovulation
The Association between Stress Level in Daily Life and Age at Natural Menopause in Korean Women: Outcomes of the Korean National Health and Nutrition Examination Survey in 2010-2012
Choi BO et al., 2015
Hormonal Agents · Progesterone and Progestins
Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence
Prior JC, 2015
Vulvovaginal Health · Vaginal Atrophy
The Recent Review of the Genitourinary Syndrome of Menopause
Kim HK et al., 2015
Hormonal Agents · Progesterone and Progestins
Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women
Prior JC et al., 2014
Clinical Practice · Practice Patterns
Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study
Parker WH et al., 2013
Ovarian Hormones · Estrogen
Premature menopause
Okeke T et al., 2013
Hormonal Agents · Progesterone and Progestins
Progesterone therapy increases free thyroxine levels--data from a randomized placebo-controlled 12-week hot flush trial
Sathi P et al., 2012
Ovarian Hormones · Estrogen
Effect of hysterectomy with ovarian preservation on ovarian function
Moorman PG et al., 2011
Hormonal Agents · Androgens and DHEA
[Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women]
Perzyło K et al., 2011
Hormonal Agents · Estrogen Preparations
Bioidentical hormone therapy
Files JA et al., 2011
Ovarian Hormones · Androgens
Acute effects of premenopausal hysterectomy with bilateral oophorectomy on serum lipids, hormonal values, inflammatory markers and metabolism
Kalyan S et al., 2011
Hormones and Bone · Estrogen and Bone
Progesterone and bone: actions promoting bone health in women
Seifert-Klauss V et al., 2010
Hormonal Agents · Progesterone and Progestins
Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy
Kalyan S et al., 2010
Breast Health · Breast Cancer Risk
Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis
Lumachi F et al., 2010
Breast Health · Breast Cancer Risk
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
Fournier A et al., 2008
Breast Health · Breast Cancer Risk
Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study
Lund E et al., 2007
Gynecologic Oncology · Endometrial Cancer
In vivo and in vitro estrogenic and progestagenic actions of Tibolone
Sadarangani A et al., 2005
Fracture Risk · Risk Factors
Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study
Barad D et al., 2005
Ovarian Hormones · Estrogen
Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation
Prior JC, 2005
Reproductive Aging · Ovarian Aging
The association of hysterectomy and menopause: a prospective cohort study
Farquhar CM et al., 2005
Hormonal Agents · Progesterone and Progestins
Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product
Hermann AC et al., 2005
Hormonal Agents · Estrogen Preparations
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators, 2002
Supplements and Botanicals · Herbal and Botanical Products
Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial
Van Patten CL et al., 2002
Ovulation Physiology · Anovulation
The ageing female reproductive axis II: ovulatory changes with perimenopause
Prior JC, 2002
Hormonal Agents · Progesterone and Progestins
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate
Nilsen J et al., 2001
Hormones and Bone · Estrogen and Bone
Perimenopausal bone loss: more than estrogen depletion
Prior JC et al., 2001
Hormonal Agents · Estrogen Preparations
[Hormone replacement therapy of menopause, heart and blood vessels]
Kuttenn F et al., 2001
Hormonal Agents · Progesterone and Progestins
Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women
Rosano GM et al., 2000
Hormonal Agents · Estrogen Preparations
Cardiovascular pharmacology of hormone replacement therapy
Rosano GM et al., 1999
Hormonal Agents · Progesterone and Progestins
Oral micronized progesterone
de Lignières B, 1999
Hormonal Agents · Estrogen Preparations
Ambulatory--not office--blood pressures decline during hormone replacement therapy in healthy postmenopausal women
van Ittersum FJ et al., 1998
Hormonal Agents · Estrogen Preparations
Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow
Cacciatore B et al., 1998
Hormonal Agents · Estrogen Preparations
Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension
Mercuro G et al., 1998
Hormonal Agents · Estrogen Preparations
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
Hulley S et al., 1998
Hormones and Bone · Estrogen and Bone
Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women
Devogelaer JP et al., 1998
Hormones and Bone · Estrogen and Bone
Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate
Prior JC et al., 1998
Hormonal Agents · Estrogen Preparations
Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism
Bhavnani BR, 1998
Hormonal Agents · Estrogen Preparations
Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy
Karjalainen A et al., 1997
Hormonal Agents · Estrogen Preparations
Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial
Snabes MC et al., 1997
Hormonal Agents · Progesterone and Progestins
Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
Miyagawa K et al., 1997
Hormonal Agents · Estrogen Preparations
Treatment of skin aging with topical estrogens
Schmidt JB et al., 1996
Hormones and Bone · Estrogen and Bone
Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study
Minaguchi H et al., 1996
Hormonal Agents · Estrogen Preparations
Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study
Haines C et al., 1996
Hormones and Bone · Estrogen and Bone
Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages
Evans SF et al., 1996
Hormonal Agents · Estrogen Preparations
Estrogen acutely increases peripheral blood flow in postmenopausal women
Volterrani M et al., 1995
Hormonal Agents · Estrogen Preparations
Effects of Estrogen or Estrogen/Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
Miller VT et al., 1995
Hormonal Agents · Progesterone and Progestins
Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
Williams JK et al., 1994
Hormonal Agents · Progesterone and Progestins
No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, crossover trial
Prior JC et al., 1994
Hormonal Agents · Estrogen Preparations
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections
Raz R et al., 1993
Osteoporosis · Diagnosis and Treatment
Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study
Tuppurainen M et al., 1993
Hormones and Bone · Estrogen and Bone
Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause
Reginster JY et al., 1993
Ovarian Hormones · Progesterone
The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone
Simon JA et al., 1993
Hormonal Agents · Estrogen Preparations
Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women
Kirkengen AL et al., 1992
Long Term Health · Metabolic Risk
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones
Dahlgren E et al., 1992
Hormones and Bone · Estrogen and Bone
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women
Ettinger B et al., 1992
Hormonal Agents · Progesterone and Progestins
Absorption of micronized progesterone from a nonliquefying vaginal cream
Kimzey LM et al., 1991
Ovarian Hormones · Progesterone
Progesterone administration by nasal spray
Cicinelli E et al., 1991
Ovarian Hormones · Estrogen
Pharmacokinetics of oestrogens and progestogens
Kuhl H, 1990
Hormonal Agents · Estrogen Preparations
Pharmacokinetics of estrogen
Stumpf PG, 1990
Ovarian Hormones · Progesterone
Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review
Sitruk-Ware R et al., 1987
Ovarian Hormones · Progesterone
Absorption and metabolism of oral progesterone when administered twice daily
Padwick ML et al., 1986
Ovarian Hormones · Progesterone
Bioavailability of oral micronized progesterone
Maxson WS et al., 1985
Ovarian Hormones · Progesterone
Intravaginal administration of progesterone: enhanced absorption after estrogen treatment
Villanueva B et al., 1981
Hormonal Agents · Estrogen Preparations
Estriol in the management of the menopause
Tzingounis VA et al., 1978
Ovarian Hormones · Estrogen
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women
Yen SS et al., 1975